Skip to main content
OpenTrials
Completed

NCT Number: NCT03416075

Mechanical Ventilation in Interstitial Lung Disease

To identify risk factors for mortality in patients with interstitial lung disease receiving mechanical ventilation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • They were clearly diagnosed as interstitial lung disease in hospital;
  • They had progressive worsening of dyspnea and their oxygenation indexes were less than 300 in ICU;
  • They received at least 48 hours of mechanical ventilation after being admitted into ICU.

Exclusion criteria

  • We excluded patients who were admitted into ICU because of postoperative monitoring.

Treatment and study plan

Mechanical ventilation

Device

Noninvasive and/or invasive mechanical ventilation were performed when patients had respiratory failure.

Primary outcomes

  1. ICU Mortality

    Time frame: 7 years

Secondary outcomes

  1. Hospital mortality

    Time frame: 7 years

  2. Noninvasive mechanical ventilation failure

    Time frame: 7 years

  3. Invasive mechanical ventilation failure

    Time frame: 7 years

Sponsors and collaborators

Lead sponsor

Beijing Chao Yang Hospital

Other

Registry information

Official study title

Risk Factors for Mortality in Patients With Interstitial Lung Disease Receiving Mechanical Ventilation: A Retrospective, Observational Cohort Study

Important dates

Study start
2011
Primary completion
2017
Study completion
2017
First posted
Jan 30, 2018
Registry last updated
Jan 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.